Review



hy 108937 d 64131 mce  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress hy 108937 d 64131 mce
    Hy 108937 D 64131 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40614706-670-85-87
    Average 93 stars, based on 12 article reviews
    hy 108937 d 64131 mce - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Injection:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: .. The 6.5-month-old APP mice were intraperitoneally (i.p.) injected with Bcl-2-associated X protein (BAX), voltage-dependent anion channel (VDAC), Cyclophilin D (CypD) or RAGE inhibitor i.e., BIP-V5 (5 mg kg−1 BW; 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% saline; HY-P0081, MCE), NSC 15364 (2.5 mg kg−1 BW; 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% saline; Cat #HY-108937, MCE), Cyclosporin A (CsA) (1 mg kg−1 BW i.p. 5% DMSO 40% PEG300 5% Tween-80 50% saline; Cat #HY-B0579, MCE) twice each week, and Azeliragon (100 mcg; 10% DMSO 40% PEG300 5% Tween-80 45% Saline; Cat #HY-50682, MCE) every day for 6 weeks. ..

    Saline:

    Article Title: Amyloid beta glycation leads to 1 neuronal mitochondrial dysfunction and Alzheimer’s pathogenesis through VDAC1-dependent mtDNA efflux
    Article Snippet: .. The 6.5-month-old APP mice were intraperitoneally (i.p.) injected with Bcl-2-associated X protein (BAX), voltage-dependent anion channel (VDAC), Cyclophilin D (CypD) or RAGE inhibitor i.e., BIP-V5 (5 mg kg−1 BW; 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% saline; HY-P0081, MCE), NSC 15364 (2.5 mg kg−1 BW; 10% DMSO + 40% PEG300 + 5% Tween-80 + 45% saline; Cat #HY-108937, MCE), Cyclosporin A (CsA) (1 mg kg−1 BW i.p. 5% DMSO 40% PEG300 5% Tween-80 50% saline; Cat #HY-B0579, MCE) twice each week, and Azeliragon (100 mcg; 10% DMSO 40% PEG300 5% Tween-80 45% Saline; Cat #HY-50682, MCE) every day for 6 weeks. ..



    Similar Products

    93
    MedChemExpress hy 108937 d 64131 mce
    Hy 108937 D 64131 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40614706-670-85-87
    Average 93 stars, based on 1 article reviews
    hy 108937 d 64131 mce - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    98
    MedChemExpress hy 15141 nsc 15364 mce
    Hy 15141 Nsc 15364 Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/Staurosporine/pm40614706-670-81-83
    Average 98 stars, based on 1 article reviews
    hy 15141 nsc 15364 mce - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    93
    MedChemExpress nsc 15364
    Nsc 15364, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm40517916-60-33-38
    Average 93 stars, based on 1 article reviews
    nsc 15364 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress apoptosis inhibitor
    Apoptosis Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pmc11617880-382-0-27
    Average 93 stars, based on 1 article reviews
    apoptosis inhibitor - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress nsc15364
    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM <t>NSC15364</t> or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.
    Nsc15364, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pmc11550314-38-5-10
    Average 93 stars, based on 1 article reviews
    nsc15364 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress gemcitabine
    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM <t>NSC15364</t> or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.
    Gemcitabine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nsc+15364/NSC+15364/pm38602878-315-11-31
    Average 93 stars, based on 1 article reviews
    gemcitabine - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM NSC15364 or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. B H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with GFP or GFP-VDAC1 for 24 h. C H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with 100 μM NSC15364 or 400 μM DIDS for 12 h. A – C The indicated protein levels were estimated by western blot analysis. Band intensities of GFP-VDAC1 were quantified using Image ( J ), normalized to β-actin intensity, and plotted as a fold change relative to the control. D H1299 cells were transfected with GFP or GFP-VDAC1 for 18 h and subsequently treated with a control or cysteine-deprived medium for the indicated time. E H1299 cells were transfected with Flag or Flag-VDAC1 for 24 h. The indicated mRNA levels were estimated by quantitative real-time PCR analysis ( n = 3; *** p < 0.001). F H1299 cells were transfected with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for 9 h. G , H H1299 cells were co-transfected with CTL or VDAC1 siRNAs along with Flag or Flag-VDAC1 for 18 h and subsequently treated with control or cysteine-deprived medium for the indicated time ( H ) or 9 h ( G ). I , J H1299 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. D , H , I , and J Cell viability was measured by MTT assay ( n = 3; *** p < 0.001). K – N H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , G A representative flow cytometry of the average MFI ± SD of C11-BODIPY staining ( n = 3; *** p < 0.001, ns not significantly different). K , L A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). M , N A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; *** p < 0.001, ns not significantly different). CTL control, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Transfection, Control, Western Blot, Real-time Polymerase Chain Reaction, Incubation, Concentration Assay, MTT Assay, Flow Cytometry, Staining, Fluorescence, Standard Deviation

    A – E H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. A A representative fluorescence microscopy image of MitoSOX red staining. The green fluorescence of MitoBright LT green shows the location of mitochondria (scale bar = 100 μm). B , C A representative flow cytometry histogram of MitoSOX staining (upper panels) and the average MFI ± SD of MitoSOX staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001, ns not significantly different). D , E A representative flow cytometry histogram of TMRE staining. F H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001, ns not significantly different). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A – E H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. A A representative fluorescence microscopy image of MitoSOX red staining. The green fluorescence of MitoBright LT green shows the location of mitochondria (scale bar = 100 μm). B , C A representative flow cytometry histogram of MitoSOX staining (upper panels) and the average MFI ± SD of MitoSOX staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001, ns not significantly different). D , E A representative flow cytometry histogram of TMRE staining. F H1299 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001, ns not significantly different). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Incubation, Control, Fluorescence, Microscopy, Staining, Flow Cytometry, Positive Control, Inhibition, Standard Deviation

    A H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 18 h. Cell viability was measured by MTT assay, ( n = 3; * p < 0.05, *** p < 0.001). B – E H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 9 h. B A representative flow cytometry histogram of C11-BODIPY staining (left panel) and the average MFI ± SD of C11-BODIPY staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). C A representative flow cytometry histogram of MitoPeDPP staining (left panel) and the average MFI ± SD of MitoPeDPP staining (right panel) ( n = 3; ** p < 0.01, *** p < 0.001). D A representative flow cytometry histogram of MitoSOX staining (left panel) and the average MFI ± SD of MitoSOX staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). E A representative flow cytometry histogram of TMRE staining (left panel) and the average MFI ± SD of TMRE staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). F H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 18 h. Cell viability was measured by MTT assay, ( n = 3; * p < 0.05, *** p < 0.001). B – E H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 9 h. B A representative flow cytometry histogram of C11-BODIPY staining (left panel) and the average MFI ± SD of C11-BODIPY staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). C A representative flow cytometry histogram of MitoPeDPP staining (left panel) and the average MFI ± SD of MitoPeDPP staining (right panel) ( n = 3; ** p < 0.01, *** p < 0.001). D A representative flow cytometry histogram of MitoSOX staining (left panel) and the average MFI ± SD of MitoSOX staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). E A representative flow cytometry histogram of TMRE staining (left panel) and the average MFI ± SD of TMRE staining (right panel) ( n = 3; *** p < 0.001, ns not significantly different). F H1299 cells were treated with 200 nM RSL3 and 100 μM NSC15364 for 2 h. The oxygen consumption was measured using an extracellular oxygen consumption assay. The dots represent the values of oxygen consumption measured at 1.5-min intervals over a period of 180 min. H1299 cells treated with 75 μM Antimycin A for 2 h were used as a positive control for oxygen consumption rate inhibition, ( n = 3; *** p < 0.001). Anti A antimycin A, Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: MTT Assay, Flow Cytometry, Staining, Positive Control, Inhibition, Fluorescence, Standard Deviation

    A , B MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. C , D HEYA8 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. A – D Cell viability was measured by MTT assay ( n = 3). E , G , I , and K MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , H , J , and L HEYA8 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 16 h. E , F A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; ** p < 0.01, *** p < 0.001, ns not significantly different). G , H A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001). I , J A representative flow cytometry histogram of MitoSOX. K , L A representative flow cytometry histogram of TMRE. Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Journal: Cell Death & Disease

    Article Title: Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

    doi: 10.1038/s41419-024-07216-1

    Figure Lengend Snippet: A , B MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. C , D HEYA8 cells were incubated in a control or cysteine-deprived medium with or without NSC15364 or DIDS for the indicated concentration for 24 h. A – D Cell viability was measured by MTT assay ( n = 3). E , G , I , and K MDA-MB-231 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 12 h. F , H , J , and L HEYA8 cells were incubated in a control or cysteine-deprived medium with or without 100 μM NSC15364 or 400 μM DIDS for 16 h. E , F A representative flow cytometry histogram of C11-BODIPY staining (upper panels) and the average MFI ± SD of C11-BODIPY staining (low panels) ( n = 3; ** p < 0.01, *** p < 0.001, ns not significantly different). G , H A representative flow cytometry histogram of MitoPeDPP staining (upper panels) and the average MFI ± SD of MitoPeDPP staining (low panels) ( n = 3; * p < 0.05, *** p < 0.001). I , J A representative flow cytometry histogram of MitoSOX. K , L A representative flow cytometry histogram of TMRE. Cys cysteine, MFI mean fluorescence intensity, NSC NSC15364, SD standard deviation, TMRE tetramethylrhodamine ethyl ester perchlorate.

    Article Snippet: DIDS sodium salt (#HY-D0086) and NSC15364 (#HY-108937) were obtained from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Incubation, Control, Concentration Assay, MTT Assay, Flow Cytometry, Staining, Fluorescence, Standard Deviation